Does RUXOLITINIB Cause Therapeutic product effect variable? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Therapeutic product effect variable have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.0% of all adverse event reports for RUXOLITINIB.
7
Reports of Therapeutic product effect variable with RUXOLITINIB
0.0%
of all RUXOLITINIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Therapeutic product effect variable From RUXOLITINIB?
Of the 7 reports, 2 (28.6%) required hospitalization.
Is Therapeutic product effect variable Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Therapeutic product effect variable?
CARBIDOPA\LEVODOPA (316)
LEVODOPA (298)
RIMEGEPANT (177)
GABAPENTIN (166)
CLOZAPINE (157)
DICLOFENAC (153)
OLANZAPINE (150)
FLUOXETINE (149)
ARIPIPRAZOLE (148)
AMISULPRIDE (147)
Which RUXOLITINIB Alternatives Have Lower Therapeutic product effect variable Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE